Associations between Plasma Ceramides and Cognitive and Neuropsychiatric Manifestations in Parkinson’s Disease Dementia

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works

The Clinical Dementia Rating (CDR): Current version and scoring rules

Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works

The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · see citing works

Principles of bioactive lipid signalling: lessons from sphingolipids

Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,331 · see citing works

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027 · see citing works

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,245 · see citing works

Prevalence and Characteristics of Dementia in Parkinson Disease

Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403 · see citing works

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K. J., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,135 · see citing works

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

Irwin, D. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3549 · Cited by 875 · see citing works

Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews

Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597 · see citing works

Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress

Aarsland, D., Brønnick, K., Ehrt, U., Deyn, P. P. D., Tekin, S., Emre, M., & Cummings, J. L. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083113 · Cited by 519 · see citing works

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475 · see citing works

Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study

Mielke, M. M., Maetzler, W., Haughey, N. J., Bandaru, V. V. R., Savica, R., Deuschle, C., Gasser, T., Hauser, A., Gräber‐Sultan, S., Schleicher, E. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073094 · Cited by 232 · see citing works

High Throughput Lipidomic Profiling of Schizophrenia and Bipolar Disorder Brain Tissue Reveals Alterations of Free Fatty Acids, Phosphatidylcholines, and Ceramides

Schwarz, E., Prabakaran, S., Whitfield, P. D., Major, H. J., Leweke, F. M., Koethe, D., McKenna, P. J., & Bahn, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800188y · Cited by 222 · see citing works

Serum sphingomyelins and ceramides are early predictors of memory impairment

Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Rabins, P. V., Lyketsos, C. G., & Carlson, M. C. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.011 · Cited by 188 · see citing works

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Schech, S., Carrick, R., Carlson, M. C., Mori, S., Miller, M. I., Ceritoglu, C., Brown, T., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.014 · Cited by 170 · see citing works

Plasma Phosphatidylcholine and Sphingomyelin Concentrations Are Associated with Depression and Anxiety Symptoms in a Dutch Family-Based Lipidomics Study

Demirkan, A., Isaacs, A., Ugocsai, P., Liebisch, G., Struchalin, M., Rudan, I., Wilson, J. F., Pramstaller, P. P., Gyllensten, U., Campbell, H., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.11.001 · Cited by 163 · see citing works

Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease

Abbott, S. K., Li, H., Muñoz, S. S., Knoch, B., Batterham, M. J., Murphy, K. E., Halliday, G. M., & Garner, B. (2013) · Movement Disorders · doi:10.1002/mds.25729 · Cited by 154 · see citing works

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa

Sacktor, N. C., Nakasujja, N., Skolasky, R. L., Robertson, K., Wong, M., Musisi, S., Ronald, A., & Katabira, E. T. (2006) · Neurology · doi:10.1212/01.wnl.0000225183.74521.72 · Cited by 136 · see citing works

Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease

Brás, J., Singleton, A., Cookson, M., & Hardy, J. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06709.x · Cited by 132 · see citing works

Ceramide‐induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation

Willaime‐Morawek, S., Vanhoutte, P., Caboche, J., Lemaigre‐Dubreuil, Y., Mariani, J., & Brugg, B. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01581.x · Cited by 127 · see citing works

Elevated Plasma Ceramides in Depression

Gracia‐García, P., Rao, V., Haughey, N. J., Bandaru, V. V. R., Smith, G. S., Rosenberg, P. B., Lobo, A., Lyketsos, C. G., & Mielke, M. M. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.2.jnp215 · Cited by 96 · see citing works

Role of dietary iron restriction in a mouse model of Parkinson's disease

Levenson, C. W., Cutler, R. G., Ladenheim, B., Cadet, J. L., Hare, J., & Mattson, M. P. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.014 · Cited by 64 · see citing works

Parkinson’s Disease and Sleep/Wake Disturbances

Suzuki, K., Miyamoto, M., Miyamoto, T., & Hirata, K. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0525-5 · Cited by 61 · see citing works

Sphingolipids in Psychiatric Disorders and Pain Syndromes

Mühle, C., Reichel, M., Gulbins, E., & Kornhuber, J. (2013) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-7091-1511-4_22 · Cited by 58 · see citing works

Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons

Martinez, T. N., Chen, X., Bandyopadhyay, S., Merrill, A. H., & Tansey, M. G. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-45 · Cited by 52 · see citing works

Defects in Very Long Chain Fatty Acid Synthesis Enhance Alpha-Synuclein Toxicity in a Yeast Model of Parkinson's Disease

Lee, Y. J., Wang, S., Slone, S. R., Yacoubian, T. A., & Witt, S. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015946 · Cited by 50 · see citing works

Activation of 5-HT1A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease

Sun, Y., Wang, T., Wang, Y., Han, L.-N., Li, L., Zhang, Y., & Liu, J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.007 · Cited by 42 · see citing works

Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors

Jafurulla, M., Pucadyil, T. J., & Chattopadhyay, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.007 · Cited by 38 · see citing works

Ceramide-Induced Alterations in Dopamine Transporter Function

Riddle, E. L., Rau, K. S., Topham, M. K., Hanson, G. R., & Fleckenstein, A. E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02727-9 · Cited by 37 · see citing works

Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease

Huot, P., Johnston, T. H., Visanji, N. P., Darr, T., Pires, D., Hazrati, L., Brotchie, J. M., & Fox, S. H. (2012) · Movement Disorders · doi:10.1002/mds.24964 · Cited by 29 · see citing works

Mutations of glucocerebrosidase gene and susceptibility to Parkinson’s disease: An updated meta-analysis in a European population

Zhao, F., Bi, L., Wang, W., Wu, X., Li, Y., Gong, F., Lu, S., Feng, F., Qian, Z., Hu, C., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.007 · Cited by 28 · see citing works

Sphingolipids as New Biomarkers for Assessment of Delayed-Type Hypersensitivity and Response to Triptolide

Qu, F., Wu, C., Hou, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052454 · Cited by 27 · see citing works

Glucocerebrosidase Gene Mutations Associated with Parkinson's Disease: A Meta-Analysis in a Chinese population

Chen, J., Li, W., Zhang, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115747 · Cited by 25 · see citing works

Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study

Saleem, M., Bandaru, V. V. R., Herrmann, N., Swardfager, W., Mielke, M. M., OH, P. I., Shammi, P., Kiss, A., Haughey, N. J., Rovinski, R., et al. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-135 · Cited by 25 · see citing works

Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers

Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36 · see citing works

Bacterial Infections and Ceramide

Grassmé, H., & Becker, K. A. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_15 · Cited by 32 · see citing works

Ceramide Signaling in Apoptosis and Cancer Therapy

Kullmann, S., Teichgrüher, V., Bollinger, C. R., et al. (2006) · doi:10.1002/9783527619665.ch39

Ceramide synthase 4 is highly expressed in involved skin of patients with atopic dermatitis

Ito, S., Ishikawa, J., Naoe, A., Yoshida, H., Hachiya, A., Fujimura, T., Kitahara, T., & Takema, Y. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13777 · Cited by 42 · see citing works

Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide

Watt, M. J., Barnett, A., Bruce, C. R., Schenk, S., Horowitz, J. F., & Hoy, A. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2649-3 · Cited by 115 · see citing works

Ceramide generation by two distinct pathways in tumor necrosis factor α‐induced cell death

Dbaibo, G. S., El-Assaad, W., Krikorian, A., et al. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02625-4 · Cited by 107 · see citing works